These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 784919)

  • 21. Inhibitors of glyoxalase enzymes.
    Oray B; Norton SJ
    Biochem Biophys Res Commun; 1980 Jul; 95(2):624-9. PubMed ID: 7417280
    [No Abstract]   [Full Text] [Related]  

  • 22. Yeast glyoxalase I. Circular dichroic spectra and pH effects.
    Douglas KT; Seddon AP; Nakagawa Y
    Int J Biochem; 1986; 18(6):549-55. PubMed ID: 3519311
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and kinetic evaluation of S- and N-substituted cysteinylglycines as inhibitors of glyoxalase I.
    Lyon PA; Vince R
    J Med Chem; 1977 Jan; 20(1):77-88. PubMed ID: 833829
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and study of glutaryl-S-(omega-aminoalkyl)-L-cysteinylglycines as inhibitors of glyoxalase I.
    Phillips GW; Norton SJ
    J Med Chem; 1975 May; 18(5):482-6. PubMed ID: 1171239
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Purification and kinetic study of glyoxalase-I from rat liver, erythrocytes, brain and kidney.
    Han LP; Davison LM; Vander Jagt DL
    Biochim Biophys Acta; 1976 Sep; 445(2):486-99. PubMed ID: 953039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Purification and characterization of glyoxalase I from Pseudomonas putida.
    Rhee H; Murata K; Kimura A
    Biochem Biophys Res Commun; 1986 Dec; 141(3):993-9. PubMed ID: 3101683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glyoxalase I and glyoxalase II from Aloe vera: purification, characterization and comparison with animal glyoxalases.
    Norton SJ; Talesa V; Yuan WJ; Principato GB
    Biochem Int; 1990 Nov; 22(3):411-8. PubMed ID: 2076100
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Purification, characterization and kinetic studies of glyoxalase I from rat liver.
    Marmstål E; Mannervik B
    Biochim Biophys Acta; 1979 Feb; 566(2):362-70. PubMed ID: 420861
    [No Abstract]   [Full Text] [Related]  

  • 29. Electrophoretic study on the DNA-breaking actions of ascorbic acid and triose reductone in the presence of Cu2+.
    Shinohara K; So M; Nonaka M; Nishiyama K; Murakami H; Omura H
    J Nutr Sci Vitaminol (Tokyo); 1983 Aug; 29(4):481-8. PubMed ID: 6644387
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A two-step purification of mouse liver glyoxalase I and evidence of its dimeric constitution.
    Oray B; Norton SJ
    Biochim Biophys Acta; 1977 Jul; 483(1):203-9. PubMed ID: 880305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological comparison of glyoxalase I from yeast and mammals and quantitative determination of the enzyme in human tissues by radioimmunoassay.
    Larsen K; Aronsson AC; Marmstål E; Mannervik B
    Comp Biochem Physiol B; 1985; 82(4):625-38. PubMed ID: 3937656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Breaking action of reductones related to ascorbic acid on nucleic acids.
    Omura H; Tomita Y; Fujiki H; Shinohara K; Murakami H
    J Nutr Sci Vitaminol (Tokyo); 1978; 24(3):263-70. PubMed ID: 690727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hydrophobic binding is not an independent stereochemical determinant in the yeast glyoxalase I reaction.
    Creighton DJ; Weiner A; Buettner L
    Biophys Chem; 1980 Apr; 11(2):265-9. PubMed ID: 6989412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of glyoxalase I: a possible transition-state analogue inhibitor approach to potential antineoplastic agents?
    Douglas KT; Nadvi IN
    FEBS Lett; 1979 Oct; 106(2):393-6. PubMed ID: 499526
    [No Abstract]   [Full Text] [Related]  

  • 35. Chemical modification of tyrosine residues in glyoxalase I from yeast and human erythrocytes.
    Carrington SJ; Fetherbe D; Douglas KT
    Int J Biochem; 1989; 21(8):901-8. PubMed ID: 2684702
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of glyoxalase I by various clinically used anticancer drugs.
    Kraus JL; Pernice P; Ponce C
    Res Commun Chem Pathol Pharmacol; 1988 Mar; 59(3):419-22. PubMed ID: 3363227
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reinvestigation of the roles of the carboxyl groups of glutathione with yeast glyoxalase I. Implications as to the mechanism and coenzymic role of glutathione.
    D'Silva C
    FEBS Lett; 1986 Jul; 202(2):240-4. PubMed ID: 3522272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Subunit structure of glyoxalase I from yeast.
    Marmstål E; Mannervik B
    FEBS Lett; 1978 Jan; 85(2):275-8. PubMed ID: 340274
    [No Abstract]   [Full Text] [Related]  

  • 39. Effects of pH and thiols on the kinetics of yeast glyoxalase I. An evaluation of the random pathway mechanism.
    Vander Jagt DL; Daub E; Krohn JA; Han LP
    Biochemistry; 1975 Aug; 14(16):3669-75. PubMed ID: 240387
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of yeast glyoxalase I by biologically active peptides.
    Kraus JL; Castaing M
    Res Commun Chem Pathol Pharmacol; 1989 Jul; 65(1):105-10. PubMed ID: 2781146
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.